1. Home
  2. AEVA vs ABSI Comparison

AEVA vs ABSI Comparison

Compare AEVA & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeva Technologies Inc.

AEVA

Aeva Technologies Inc.

N/A

Current Price

$14.28

Market Cap

1.1B

ML Signal

N/A

Logo Absci Corporation

ABSI

Absci Corporation

N/A

Current Price

$10.81

Market Cap

997.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEVA
ABSI
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
997.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AEVA
ABSI
Price
$14.28
$10.81
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
★ $30.00
$14.40
AVG Volume (30 Days)
1.2M
★ 3.3M
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
10.53
★ 10.64
EPS
N/A
★ N/A
Revenue
N/A
★ $4,534,000.00
Revenue This Year
$78.97
$39.03
Revenue Next Year
$124.76
$314.76
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$8.83
$2.24
52 Week High
$31.30
$12.06

Technical Indicators

Market Signals
Indicator
AEVA
ABSI
Relative Strength Index (RSI) 38.47 62.14
Support Level $13.95 $8.17
Resistance Level $14.30 $11.26
Average True Range (ATR) 0.81 0.71
MACD 0.05 0.16
Stochastic Oscillator 11.26 87.30

Price Performance

Historical Comparison
AEVA
ABSI

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Share on Social Networks: